|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/68 | |
| A61P 35/00 |
| (11) | Patento numeris | 2788030 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12798723.8 |
| Europos patento paraiškos padavimo data | 2012-12-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/074867 |
| Data | 2012-12-07 |
| (87) | Numeris | WO 2013/083817 |
| Data | 2013-06-13 |
| (30) | Numeris | Data | Šalis |
| 201161568640 P | 2011-12-08 | US | |
| 201261722367 P | 2012-11-05 | US |
| (72) |
SCHULZ, Gregor, DE
OSTERROTH, Frank, DE
HAEDER, Thomas, DE
BRUECHER, Christoph, DE
NIEMANN, Gabriele, DE
ENGLING, Andre, DE
UHEREK, Christoph, DE
DAELKEN, Benjamin, DE
WARTENBERG-DEMAND, Andrea, DE
ZUBER, Chantal, DE
GUTSCHER, Marcus, DE
BERNOESTER, Katrin, DE
KOENIG, Martin, DE
|
| (73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451,
US
Biotest AG, Landsteinerstr. 5, 63303 Dreieich, DE |
| (54) | USES OF IMMUNOCONJUGATES TARGETING CD138 |
| USES OF IMMUNOCONJUGATES TARGETING CD138 |